Home HIV Medicine FAQ Unsubscribe Change Email Policy About Flying Publisher   

New: InfluenzaReport.com
A Medical Textbook, 250 pages

  Bladder Cancer, May 2006

Free Subscription


Abstracts

Retrieve all available abstracts of the following 102 articles:
HTML format


 

Single Articles

  1. HILTON L
    Urine test boosts detection of recurrent bladder cancer.
    RN. 2006;69:3-4.
    Abstract     Related articles   



  2. MILLAR JL , Frydenberg M, Toner G, Syme R, et al
    Management of muscle-invasive bladder cancer in Victoria, 1990-1995.
    ANZ J Surg. 2006;76:113-9.
    Abstract     Related articles   

    Abstract available

  3. LIN HC , Wu WJ, Ke HL, Huang CH, et al
    Bladder leiomyoma presenting as voiding dysfunction: a case report.
    Kaohsiung J Med Sci. 2006;22:154-7.
    Abstract     Related articles   

    Abstract available

  4. AL'-SHUKRI SKH , Korneev IA, Boikov VV, Nevirovich ES, et al
    [Recurrent extranodal B-cell (MALT) lymphoma of the urinary bladder]
    Urologiia. 2006;:67-8.
    Abstract     Related articles   



  5. DARENKOV SP , Kovalev VA, Ochcharhadzhiev SB, Dzitiev VK, et al
    [Intestinal replacement of the urinary bladder with creation of continent cutaneostomy]
    Urologiia. 2006;:33-8.
    Abstract     Related articles   

    Abstract available

  6. COSKUN U , Sancak B, Sen I, Bukan N, et al
    Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages.
    Int Immunopharmacol. 2006;6:672-7.
    Abstract     Related articles   

    Abstract available

  7. HAMMOUDA H , Shalaby M, Adelelateef A, Elakkad M, et al
    Mainz II and double folded rectosigmoid pouches. Experience with 95 patients.
    J Surg Oncol. 2006;93:228-32.
    Abstract     Related articles   

    Abstract available

  8. SHAFAT I , Zcharia E, Nisman B, Nadir Y, et al
    An ELISA method for the detection and quantification of human heparanase.
    Biochem Biophys Res Commun. 2006;341:958-63.
    Abstract     Related articles   

    Abstract available

  9. HUSSEIN MR , Nassar MI, Kamel NA, Osman ME, et al
    Analysis of fibronectin expression in the bilharzial granulomas and of laminin in the transformed urothelium in schistosoma haematobium infested patients.
    Cancer Biol Ther. 2005;4:676-8.
    Abstract     Related articles   

    Abstract available

  10. ZUO Z , Zhao M, Liu J, Gao G, et al
    Functional Analysis of Bladder Cancer-Related Protein Gene: A Putative Cervical Cancer Tumor Suppressor Gene in Cervical Carcinoma.
    Tumour Biol. 2006;27:221-226.
    Abstract     Related articles   

    Abstract available

  11. GOEBELL PJ , Vom Dorp F, Rubben H
    [Value of systemic chemotherapy in bladder cancer.]
    Urologe A. 2006;.
    Abstract     Related articles   

    Abstract available

  12. BOHLE A , Suttmann H, Brandau S
    [Effect mechanism of intravesical BCG immunotherapy of superficial bladder cancer.]
    Urologe A. 2006;.
    Abstract     Related articles   

    Abstract available

  13. PASSAPERUMA K , Ash R, Venkatesan V, Rodrigues G, et al
    Pelvic chemoradiotherapy after chemotherapy for metastatic bladder cancer.
    Can J Urol. 2006;13:3009-15.
    Abstract     Related articles   

    Abstract available

  14. FECHNER G , Pocha K, Schmidt D, Muller SC, et al
    Reducing recurrence and costs in superficial bladder cancer: preclinical evaluation of osmotic cytolysis by distilled water vs. mitomycin.
    Int J Clin Pract. 2006;.
    Abstract     Related articles   

    Abstract available

  15. AMENDOLA P , Audisio R, Scaburri A, Ariano E, et al
    [The active search for occupational cancer cases: bladder cancer in Lombardy Region]
    Epidemiol Prev. 2005;29.
    Abstract     Related articles   

    Abstract available

  16. STERN MC , Conway K, Li Y, Mistry K, et al
    DNA repair gene polymorphisms and probability of p53 mutation in bladder cancer.
    Mol Carcinog. 2006;.
    Abstract     Related articles   

    Abstract available

  17. SANTOS ARRONTES D , Fernandez Arjona M, Valer Lopez-Fando MP, Pascual Mateo C, et al
    [Tobacco consumption and bladder cancer mortality in Spain]
    Arch Esp Urol. 2006;59:141-5.
    Abstract     Related articles   

    Abstract available

  18. KINOSHITA H , Sato Y, Chizaki R, Kawa G, et al
    [Experience of laparoscopic nerve-sparing radical cystectomy and construction of ileal neobladder at Kansai Medical University]
    Hinyokika Kiyo. 2006;52:231-4.
    Abstract     Related articles   

    Abstract available

  19. HORI J , Okuyama M, Azumi M, Kato Y, et al
    [Clinical significance of cystoscopy in transrectal prostate biopsy]
    Hinyokika Kiyo. 2006;52:185-8.
    Abstract     Related articles   

    Abstract available

  20. TOSCHI L , Finocchiaro G, Bartolini S, Gioia V, et al
    Role of gemcitabine in cancer therapy.
    Future Oncol. 2005;1:7-17.
    Abstract     Related articles   

    Abstract available

  21. RAMMEH-ROMMANI S , Zermani R, Zouari B, Sfaxi M, et al
    [Prognostic value of clinicopathologic factors in superficial bladder tumors: a retrospective analysis]
    Tunis Med. 2005;83:746-9.
    Abstract     Related articles   

    Abstract available

  22. TRASCA E , Buzulica R, Plesan C, Nicolescu I, et al
    The role of histological examination for prognostic evaluation and therapeutic algorithm in urinary bladder tumors.
    Rom J Morphol Embryol. 2005;46:225-8.
    Abstract     Related articles   

    Abstract available

  23. PAGLIERANI M , Castiglione F, Garbini F, Buccoliero AM, et al
    [FISH and thin layer in urinary cytology]
    Pathologica. 2005;97:200.
    Abstract     Related articles   



  24. JOHANSSON B , Ridderheim M, Glimelius B
    The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
    Acta Oncol. 2005;44:890-5.
    Abstract     Related articles   

    Abstract available

  25. BARGHI MR , Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B, et al
    Correlation between human papillomavirus infection and bladder transitional cell carcinoma.
    BMC Infect Dis. 2005;5:102.
    Abstract     Related articles   

    Abstract available   Free Full Text

  26. PAPAGEORGIOU EI , Spyridonos PP, Stylios CD, Ravazoula P, et al
    Advanced soft computing diagnosis method for tumour grading.
    Artif Intell Med. 2006;36:59-70.
    Abstract     Related articles   

    Abstract available

  27. SROUGI M , Antunes AA, Dall'oglio MF, Cury J, et al
    Management of panurothelial disease in superficial bladder cancer.
    Nat Clin Pract Urol. 2006;3:284-288.
    Abstract     Related articles   

    Abstract available

  28. DEVERE WHITE RW
    Transurethral resection of superficial bladder cancer using 5-aminolevulinic acid: are there any long-term benefits?
    Nat Clin Pract Urol. 2006;3:254-5.
    Abstract     Related articles   



  29. KRAUSE FS , Rauch A, Schrott KM, Engehausen DG, et al
    Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?
    World J Urol. 2006;.
    Abstract     Related articles   

    Abstract available

  30. STEINMAUS C , Bates MN, Yuan Y, Kalman D, et al
    Arsenic Methylation and Bladder Cancer Risk in Case-Control Studies in Argentina and the United States.
    J Occup Environ Med. 2006;48:478-488.
    Abstract     Related articles   

    Abstract available

  31. ZHANG JH , Yang WM, Zhou SW, Chen Z, et al
    [Effects of PTEN Gene Transfection on Proliferation and Invasion of Human Bladder Cancer Cell Line BIU87.]
    Ai Zheng. 2006;25:555-9.
    Abstract     Related articles   

    Abstract available   Free Full Text

  32. STEIN JP
    The importance of lymphovascular invasion in patients undergoing radical cystectomy for bladder cancer.
    Nat Clin Pract Oncol. 2006;3:246-7.
    Abstract     Related articles   



  33. SEE WA
    Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer Lehmann J, Franzaring L, Thuroff J, Wellek S, Stockle M, Departments of Urology and Paediatric Urology, Saar
    Urol Oncol. 2006;24:275-6.
    Abstract     Related articles   

    Abstract available

  34. SEE WA
    Treatment delay and prognosis in invasive bladder cancer Liedberg F, Anderson H, Mansson W, Department of Urology, Lund University Hospital, Lund, Sweden.
    Urol Oncol. 2006;24:274.
    Abstract     Related articles   

    Abstract available

  35. SEE WA
    Surveillance for recurrent bladder cancer using a point-of-care proteomic assay Grossman HB, Soloway M, Messing E, Katz G, Stein B, Kassabian V, Shen Y, Department of Urology, M.D. Anderson Cancer Center, Houston, TX.
    Urol Oncol. 2006;24:274-5.
    Abstract     Related articles   

    Abstract available

  36. SEE WA
    NAT2 slow acetylation and bladder cancer in workers exposed to benzidine Carreon T, Ruder AM, Schulte PA, Hayes RB, Rothman N, Waters M, Grant DJ, Boissy R, Bell DA, Kadlubar FF, Hemstreet GP III, Yin S, LeMasters GK, Division of Surveillance, Hazard
    Urol Oncol. 2006;24:273.
    Abstract     Related articles   

    Abstract available

  37. GROSSMAN HB
    Is adjuvant chemotherapy for bladder cancer safer in patients with an ileal conduit than a neobladder? Manoharan M, Reyes MA, Kava BR, Singal R, Kim SS, Soloway, MS, Department of Urology, University of Miami School of Medicine, Miami, FL.
    Urol Oncol. 2006;24:272.
    Abstract     Related articles   

    Abstract available

  38. GROSSMAN HB
    Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: A randomised controlled trial Di Stasi SM, Giannantoni A, Giurioli A, Valenti M, Zampa G, Storti L, Attisani F, De Carolis A, Capelli G, Vespasiani G
    Urol Oncol. 2006;24:271-2.
    Abstract     Related articles   

    Abstract available

  39. ROSATO A , Banzato A, De Luca G, Renier D, et al
    HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer().
    Urol Oncol. 2006;24:207-15.
    Abstract     Related articles   

    Abstract available

  40. DOBBS HJ
    Defining the radiation target on a daily basis.
    Cancer Imaging. 2006;6:30-2.
    Abstract     Related articles   

    Abstract available

  41. HORNAK M , Bardos A, Galbavy S
    Urinary bladder carcinoma: the lesson taken from the past and the future prospect.
    Bratisl Lek Listy. 2005;106:378.
    Abstract     Related articles   



  42. LIU B , Wang Z, Chen B, Yu J, et al
    Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
    Cancer Invest. 2006;24:160-3.
    Abstract     Related articles   

    Abstract available

  43. WEINREB DB , Desman GT, Amolat-Apiado MJ, Burstein DE, et al
    Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals.
    Diagn Cytopathol. 2006;34:201-3.
    Abstract     Related articles   

    Abstract available

  44. POCHEC E , Litynska A, Bubka M, Amoresano A, et al
    Characterization of the oligosaccharide component of alpha3beta1 integrin from human bladder carcinoma cell line T24 and its role in adhesion and migration.
    Eur J Cell Biol. 2006;85:47-57.
    Abstract     Related articles   

    Abstract available

  45. AGARWAL A , Verma S, Burra U, Murthy NS, et al
    Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder.
    Cancer Immunol Immunother. 2006;55:734-43.
    Abstract     Related articles   

    Abstract available

  46. WIEDEMANN A , Jaussi R, Rabs U
    [Isolated neurofibromatosis of the urinary bladder. A rare cause of recurrent cystitis]
    Urologe A. 2006;45:215-8.
    Abstract     Related articles   

    Abstract available

  47. VAIDYANATHAN S , Mansour P, Soni BM, Hughes PL, et al
    Chronic lymphocytic leukaemia, synchronous small cell carcinoma and squamous neoplasia of the urinary bladder in a paraplegic man following long-term phenoxybenzamine therapy.
    Spinal Cord. 2006;44:188-91.
    Abstract     Related articles   

    Abstract available

  48. GRASLAND A , Grossin M, Vinceneux P
    [Painful muscular hypertrophy]
    Rev Med Interne. 2006;27:255-6.
    Abstract     Related articles   



  49. BOHLE A , Suttmann H, Brandau S
    [Effect mechanism of intravesical BCG immunotherapy of superficial bladder cancer.]
    Urologe A. 2006;45:629-636.
    Abstract     Related articles   

    Abstract available

  50. GOEBELL PJ , Vom Dorp F, Rubben H
    [Value of systemic chemotherapy in bladder cancer.]
    Urologe A. 2006;45:586-593.
    Abstract     Related articles   

    Abstract available

  51. ATTALLAH AM , Sakr HA, Ismail H, Ismail MF, et al
    Rapid diagnosis and follow up of bladder cancer patients using urinary high molecular weight cytokeratins.
    World J Urol. 2006;.
    Abstract     Related articles   

    Abstract available

  52. FEIL G , Stenzl A
    [Tumor marker tests in bladder cancer]
    Actas Urol Esp. 2006;30:38-45.
    Abstract     Related articles   

    Abstract available

  53. NG CS
    Radiologic diagnosis and staging of renal and bladder cancer.
    Semin Roentgenol. 2006;41:121-38.
    Abstract     Related articles   



  54. HAH SS , Stivers KM, de Vere White RW, Henderson PT, et al
    Kinetics of Carboplatin-DNA Binding in Genomic DNA and Bladder Cancer Cells As Determined by Accelerator Mass Spectrometry.
    Chem Res Toxicol. 2006;19:622-626.
    Abstract     Related articles   

    Abstract available

  55. YOKOYAMA M , Kobayashi T, Kubo Y, Kageyama Y, et al
    [A case of secondary malignant lymphoma of the urinary bladder]
    Hinyokika Kiyo. 2006;52:285-7.
    Abstract     Related articles   

    Abstract available

  56. YUMURA Y , Oogo Y, Takase K, Kato Y, et al
    [Clinical analysis of double cancer involving bladder and prostate]
    Hinyokika Kiyo. 2006;52:255-8.
    Abstract     Related articles   

    Abstract available

  57. HERR HW
    Early history of endoscopic treatment of bladder tumors from Grunfeld's polypenkneipe to the Stern-McCarthy resectoscope.
    J Endourol. 2006;20:85-91.
    Abstract     Related articles   



  58. VOLPI A , Bravaccini S, Medri L, Cerasoli S, et al
    Usefulness of immunological detection of the human telomerase reverse transcriptase.
    Cell Oncol. 2005;27.
    Abstract     Related articles   

    Abstract available

  59. SANDHU JS , Vickers AJ, Bochner B, Donat SM, et al
    Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.
    BJU Int. 2006;.
    Abstract     Related articles   

    Abstract available

  60. SAKANO S , Kumar R, Larsson P, Onelov E, et al
    A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder.
    BJU Int. 2006;97:847-51.
    Abstract     Related articles   

    Abstract available

  61. PIETRZAK P , Arya M, Patel HR
    Anti-emetic therapy: updating urological cancer-care providers.
    BJU Int. 2006;97:673-5.
    Abstract     Related articles   



  62. BIRTLE AJ , Huddart RA
    Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    BJU Int. 2006;97:1348.
    Abstract     Related articles   



  63. ANDERSEN JB , Aaboe M, Borden EC, Goloubeva OG, et al
    Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer.
    Br J Cancer. 2006;.
    Abstract     Related articles   

    Abstract available

  64. IVIL KD , Doak SH, Jenkins SA, Parry EM, et al
    Fluorescence in-situ hybridisation on biopsies from clam ileocystoplasties and on a clam cancer.
    Br J Cancer. 2006;94:891-5.
    Abstract     Related articles   

    Abstract available

  65. MEMON AA , Sorensen BS, Meldgaard P, Fokdal L, et al
    The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients.
    Br J Cancer. 2006;.
    Abstract     Related articles   

    Abstract available

  66. HOLLENBECK BK , Miller DC, Taub D, Dunn RL, et al
    Risk factors for adverse outcomes after transurethral resection of bladder tumors.
    Cancer. 2006;106:1527-35.
    Abstract     Related articles   

    Abstract available

  67. ALLAREDDY V , Kennedy J, West MM, Konety BR, et al
    Quality of life in long-term survivors of bladder cancer.
    Cancer. 2006;.
    Abstract     Related articles   

    Abstract available

  68. LIN CC , Hsu CH, Huang CY, Cheng AL, et al
    Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity.
    Cancer. 2006;106:1269-75.
    Abstract     Related articles   

    Abstract available

  69. MHAWECH-FAUCEGLIA P , Cheney RT, Schwaller J
    Genetic alterations in urothelial bladder carcinoma: an updated review.
    Cancer. 2006;106:1205-16.
    Abstract     Related articles   

    Abstract available

  70. SHEN SS , Smith CL, Hsieh JT, Yu J, et al
    Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Cancer. 2006;.
    Abstract     Related articles   

    Abstract available

  71. ESTRADA CR , Salanga M, Bielenberg DR, Harrell WB, et al
    Behavioral profiling of human transitional cell carcinoma ex vivo.
    Cancer Res. 2006;66:3078-86.
    Abstract     Related articles   

    Abstract available

  72. BERNARD-PIERROT I , Brams A, Dunois-Larde C, Caillault A, et al
    Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.
    Carcinogenesis. 2006;27:740-7.
    Abstract     Related articles   

    Abstract available

  73. ISHIMURA H , Takahashi T, Nakagawa H, Nishimura S, et al
    N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer.
    Clin Cancer Res. 2006;12:2506-11.
    Abstract     Related articles   

    Abstract available

  74. KOSUGI M , Miyajima A, Kikuchi E, Horiguchi Y, et al
    Angiotensin II Type 1 Receptor Antagonist Candesartan as an Angiogenic Inhibitor in a Xenograft Model of Bladder Cancer.
    Clin Cancer Res. 2006;12:2888-93.
    Abstract     Related articles   

    Abstract available

  75. YAMAMOTO Y , Matsuyama H, Kawauchi S, Furuya T, et al
    Biological characteristics in bladder cancer depend on the type of genetic instability.
    Clin Cancer Res. 2006;12:2752-8.
    Abstract     Related articles   

    Abstract available

  76. SHERIF A , Garske U, Torre MD, Thorn M, et al
    Hybrid SPECT-CT: An Additional Technique for Sentinel Node Detection of Patients with Invasive Bladder Cancer.
    Eur Urol. 2006;.
    Abstract     Related articles   

    Abstract available

  77. AGERBAEK M , Alsner J, Marcussen N, Lundbeck F, et al
    Focal S100A4 Protein Expression Is an Independent Predictor of Development of Metastatic Disease in Cystectomized Bladder Cancer Patients.
    Eur Urol. 2006;.
    Abstract     Related articles   

    Abstract available

  78. MAFFEZZINI M
    Re: Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DWW, Kurth K. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2
    Eur Urol. 2006;.
    Abstract     Related articles   



  79. SYLVESTER RJ
    Reply to Dr Maffezzini Letter to the Editor re: Sylvester RJ, van der Meijden APM, Oosterlinck W, J. Witjes A, Bouffioux C, Denis L, Newling DWW, Kurth K. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Usi
    Eur Urol. 2006;.
    Abstract     Related articles   



  80. PASSEROTTI CC , Bonfim A, Martins JR, Dall'Oglio MF, et al
    Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder.
    Eur Urol. 2006;49:71-5.
    Abstract     Related articles   

    Abstract available

  81. ZELLWEGER T , Benz G, Cathomas G, Mihatsch MJ, et al
    Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer.
    Int J Cancer. 2006;.
    Abstract     Related articles   

    Abstract available

  82. KANEKO T , Fujita K, Homma Y
    Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guerin instillations for superficial bladder cancer.
    Int J Urol. 2006;13:294-5.
    Abstract     Related articles   

    Abstract available

  83. WEISS C , Wolze C, Engehausen DG, Ott OJ, et al
    Radiochemotherapy After Transurethral Resection for High-Risk T1 Bladder Cancer: An Alternative to Intravesical Therapy or Early Cystectomy?
    J Clin Oncol. 2006;24:2318-2324.
    Abstract     Related articles   

    Abstract available

  84. AKKAD T , Gozzi C, Deibl M, Muller T, et al
    Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.
    J Urol. 2006;175:1268-71.
    Abstract     Related articles   

    Abstract available

  85. MESSING EM
    Bladder tumor markers.
    J Urol. 2006;175:1195-6.
    Abstract     Related articles   



  86. MASOOD S , Pietrzak P, Kourief C, Vieira I, et al
    Re: treatment delay and prognosis in invasive bladder cancer f. Liedberg, h. Anderson and w. Mansson.
    J Urol. 2006;175:2364.
    Abstract     Related articles   



  87. MOUSSA O , Abol-Enein H, Bissada NK, Keane T, et al
    Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
    J Urol. 2006;175:2312-6.
    Abstract     Related articles   

    Abstract available

  88. FISHER HA
    Bladder cancer: in search of the right operation for the right patient.
    J Urol. 2006;175:1987-8.
    Abstract     Related articles   



  89. BERTHIER A , Gobet F, Bugel H, Roquet L, et al
    [Nested variant urothelial carcinoma: diagnostic difficulties]
    Prog Urol. 2005;15:729-32.
    Abstract     Related articles   

    Abstract available

  90. IRANI J , Lebret T, Theodore C, Davin JL, et al
    [Follow-up of urothelial tumours. Guidelines of the Comite de Cancerologie de l'Association Francaise d'Urologie]
    Prog Urol. 2005;15:581-6.
    Abstract     Related articles   

    Abstract available

  91. GHEZALA W , Saidi R, Lefi M, Saad H, et al
    [Florid glandular cystitis]
    Prog Urol. 2005;15:1141-4.
    Abstract     Related articles   

    Abstract available

  92. KHALLOUK A , Wallerand H, Kleinclauss F, Debiere F, et al
    [Bladder leiomyoma treated by transurethral endoscopic resection]
    Prog Urol. 2005;15:1135-7.
    Abstract     Related articles   

    Abstract available

  93. CAMPOS-FERNANDES JL , Fassi-Fehri H, Badet L, Colombel M, et al
    [Complications and functional results of Hautmann ileal bladder in a series of 87 patients]
    Prog Urol. 2005;15:1074-9.
    Abstract     Related articles   

    Abstract available

  94. KITAMURA H , Torigoe T, Honma I, Asanuma H, et al
    Expression and Antigenicity of Survivin, an Inhibitor of Apoptosis Family Member, in Bladder Cancer: Implications for Specific Immunotherapy.
    Urology. 2006;.
    Abstract     Related articles   

    Abstract available

  95. SENGUPTA S , Blute ML
    The management of superficial transitional cell carcinoma of the bladder.
    Urology. 2006;67.
    Abstract     Related articles   

    Abstract available

  96. LIOU LS
    Urothelial cancer biomarkers for detection and surveillance.
    Urology. 2006;67.
    Abstract     Related articles   

    Abstract available

  97. TUNCA F , Sanli O, Demirkol K, Gulluoglu M, et al
    Inflammatory pseudotumor of urachus mimicking invasive carcinoma of bladder.
    Urology. 2006;67:623.
    Abstract     Related articles   

    Abstract available

  98. SPIESS PE , Kassouf W, Brown G, Highshaw R, et al
    Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?
    Urology. 2006;67:466-71.
    Abstract     Related articles   

    Abstract available

  99. YAMASAKI Y , Smith C, Weisz D, van Huizen I, et al
    Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder.
    Urology. 2006;67:530-5.
    Abstract     Related articles   

    Abstract available

  100. BID HK , Manchanda PK, Mittal RD
    Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
    Urology. 2006;67:1099-104.
    Abstract     Related articles   

    Abstract available

  101. ANANTHANARAYANAN V , Deaton RJ, Yang XJ, Pins MR, et al
    Alteration of Proliferation and Apoptotic Markers in Normal and Premalignant Tissue Associated with Prostate Cancer.
    BMC Cancer. 2006;6:73.
    Abstract     Related articles   

    Abstract available   Free Full Text

  102. CHAFFER CL , Thomas DM, Thompson EW, Williams ED, et al
    PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.
    BMC Cancer. 2006;6:53.
    Abstract     Related articles   

    Abstract available   Free Full Text

Thank you for your interest in scientific medicine.


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design:


;